Filters: keyword is Serotonin [Clear All Filters]
- 2008
Mechanistic model for the acute effect of fluvoxamine on 5-HT and 5-HIAA concentrations in rat frontal cortex,
Eur J Pharm Sci, vol. 33, no. 3, pp. 217-29. DOI
- 2007
Allometric scaling of pharmacodynamic responses: application to 5-Ht1A receptor mediated responses from rat to man,
Pharm Res, vol. 24, no. 11, pp. 2031-9. DOI
Pharmacokinetic-pharmacodynamic modeling of the effect of fluvoxamine on p-chloroamphetamine-induced behavior,
Eur J Pharm Sci, vol. 32, no. 3, pp. 200-8. DOI
Population pharmacokinetic model of fluvoxamine in rats: utility for application in animal behavioral studies,
Eur J Pharm Sci, vol. 30, no. 1, pp. 45-55. DOI
- 2006
A model-based approach to treatment comparison in acute migraine,
Br J Clin Pharmacol, vol. 62, no. 5, pp. 591-600. DOI
- 2004
Mechanism-based pharmacokinetic-pharmacodynamic modeling of 5-HT1A receptor agonists: estimation of in vivo affinity and intrinsic efficacy on body temperature in rats,
J Pharmacol Exp Ther, vol. 308, no. 3, pp. 1012-20. DOI
- 2002
Pharmacokinetic-pharmacodynamic modelling of the hypothermic and corticosterone effects of the 5-HT1A receptor agonist flesinoxan,
Eur J Pharmacol, vol. 445, no. 1-2, pp. 43-54. DOI
Pharmacokinetic-pharmacodynamic modeling of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine in rats,
J Pharmacol Exp Ther, vol. 303, no. 3, pp. 1130-7. DOI
- 2001
Population pharmacokinetic-pharmacodynamic modelling of S 15535, a 5-HT(1A) receptor agonist, using a behavioural model in rats,
Eur J Pharmacol, vol. 414, no. 2-3, pp. 233-43. DOI
- 2000
Enantioselective high-performance liquid chromatographic analysis of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin. Application to a pharmacokinetic-pharmacodynamic study in rats,
J Chromatogr B Biomed Sci Appl, vol. 738, no. 1, pp. 67-73.


